| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |